Shinya Yamanaka: Because of this technology, iPS technology, now we can prepare many types of human cells. For example, heart cells — cardiac cells — or neural cells from patients. So you can easily imagine that without this technology, it’s impossible to take cardiac cells from patients who have some kinds of cardiac diseases. If the patient dies, we may be able to get a small amount of cardiac cells from that patient, but those cells do not proliferate, so we cannot increase the number. But with this technology, all we need is a small piece of skin from that patient, and by making iPS cells, we can increase the number of cells as much as we want. And then we can make cardiac cells from those iPS cells. So I think for the first time in the history of medicine, we now have an opportunity to prepare many, many cardiac or neural cells directly from patients, and those cells should be very, very useful, to understand why those patients become sick. And to search for very effective drugs for that patient, and also to study — to predict — any side effect for that particular patient. So that is the most beautiful approach — I mean application — of this iPS cell technology.